6709.TWO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

DCF fair valuemodel estimate

Intrinsic value

$0.85

Price

$23.70

Implied downside

-96%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
6709.TWOAdvagene Biopharma Co., Ltd.	$23.70	-3.85%	$1.6B	—
1762.TWChunghwa Chemical Synthesis & Biotech Co., Ltd.	$33.80	+0.45%	$2.6B	—
4172.TWOInnoPharmax Inc.	$10.60	+0.00%	$1.2B	—
4195.TWOGenomics BioSci & Tech. Co.,Ltd.	$29.45	+0.00%	$2.4B	—
4724.TWOMeribank Biotech Co., Ltd	$10.30	+16.12%	$989M	—
6130.TWOShangya Technology Co., Ltd.	$24.05	-0.62%	$1.1B	—
6564.TWOEnimmune corporation	$16.95	+0.89%	$1.2B	—

Source: Financial Modeling Prep · peers by sector/industry

Advagene Biopharma Co., Ltd.

Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to pioneering advancements in vaccine science and associated medical solutions. Its current development portfolio comprises a nasal spray vaccine for influenza, various allergy-specific vaccines, and an immunotherapy targeting COVID-19.

www.advagene.com.tw

Employees: 16
IPO / List date: Nov 29, 2018
HQ: TW

Held by traders on TradeandTell

No one on the platform currently holds 6709.TWO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 6709.TWO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 6709.TWO yet.